Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook
09 août 2017 16h05 HE
|
Organovo, Inc.
SAN DIEGO, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported financial results for the fiscal first quarter of 2018 and affirmed its full-year...
Organovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver Disease
31 juil. 2017 08h05 HE
|
Organovo, Inc.
SAN DIEGO, July 31, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has received a three-year, $1.7 million grant from the National Institutes of...
Organovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results
18 juil. 2017 08h05 HE
|
Organovo, Inc.
SAN DIEGO, July 18, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, August 9, 2017 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook
07 juin 2017 16h05 HE
|
Organovo, Inc.
SAN DIEGO, June 07, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported financial results for the fiscal fourth quarter of 2017 and issued its full-year fiscal...
Organovo to Present at Jefferies Healthcare Conference
05 juin 2017 08h05 HE
|
Organovo, Inc.
SAN DIEGO, June 05, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues at World Advanced Therapies and Regenerative Medicine Congress
18 mai 2017 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 18, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Release Date for Fiscal Fourth-Quarter 2017 Financial Results
17 mai 2017 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 17, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Collaborates With University of Virginia to Develop Bioprinted Tissues for Volumetric Muscle Loss Injury
01 mai 2017 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 01, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
24 avr. 2017 17h00 HE
|
Organovo, Inc.
SAN DIEGO, April 24, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo” or the “Company”), a three-dimensional biology company focused on delivering scientific and medical...
Organovo Announces CEO Transition
11 avr. 2017 16h05 HE
|
Organovo, Inc.
Taylor J. Crouch Named Chief Executive Officer, Effective April 24, 2017 Keith Murphy to Step Down as Chief Executive Officer, Remains on Board of Directors SAN DIEGO, April 11, 2017 (GLOBE...